Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Translational Research

The 7 questions we must answer to beat cancer

Seven months ago we set about finding the biggest challenges in cancer research.

The world’s best scientific minds worked together with patients to settle on the...

Recently funded research – understanding what makes cancer tick

Thanks to your support, we’re able to fund research into many different aspects of cancer, from treating it to diagnosing it earlier and developing strategies to try and...

Targeting cancer’s self-defence mechanisms

Dr John Halsall and Professor Bryan Turner, from the Chromatin and Gene Expression Group at the University of Birmingham, write about their latest research.

We...

Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge

A new laboratory has been opened this week in Cambridge by life sciences minister George Freeman MP

Two years on for our pioneering TRACERx lung cancer study

It should have been a dream holiday – a perfect escape from England’s January chills for a retired couple. Terrence, 75, was relaxing on deck with a book as the cruise...

Fishing for clues – how ‘liquid biopsies’ are uncovering cancer’s secrets

It takes just three minutes for a precious 10 millilitre blood sample to be carried from the specialist cancer wards of the Christie Hospital in Manchester, down a...

The Manchester Cancer Research Centre – ‘A real powerhouse for cancer research’

The new Manchester Cancer Research Centre building, a £28.5million partnership between Cancer Research UK, The University of Manchester, and The Christie NHS Foundation...

Experimental drugs aim to tackle melanoma 'escape route'

Manchester researchers are developing a new generation of targeted melanoma drugs that could bypass treatment resistance seen with current therapies.

Combination treatment halves deaths from locally advanced prostate cancer

A treatment approach combining radiotherapy with 6 months of prior hormone therapy could halve the risk of death from locally advanced prostate cancer

CRT to licence telomere targeting agents to Pharminox for drug development

Cancer Research Technology (CRT) - Cancer Research UK's development and commercial arm - and the cancer drug discovery company Pharminox Ltd (Pharminox) today announced...

Pages